MONTREAL -- (MARKET WIRE) -- April 24, 2007 -- TOPIGEN Pharmaceuticals Inc., a clinical stage biopharmaceutical company specializing in respiratory disorders, today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present an update on the company’s clinical programs at two upcoming conferences: BioFinance 2007 and the 2007 BIO International Convention.
